Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: An open-label, randomised controlled trial

The Lancet

Volumn 384, Issue 9953, 2014, Pages 1505-1512

  John, Jacob ^a   Giri, Sidhartha ^a   Karthikeyan, Arun S ^a   Iturriza Gomara, Miren ^a,b   Muliyil, Jayaprakash ^a   Abraham, Asha ^a   Grassly, Nicholas C ^a,c   Kang, Gagandeep ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

POLIOMYELITIS VACCINE; ORAL POLIOMYELITIS VACCINE; VIRUS ANTIBODY;

ANTIBODY TITER; ARTICLE; CHILD; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; IMMUNITY; IMMUNOGENICITY; INTESTINAL IMMUNITY; MALE; OUTCOME ASSESSMENT; POLIOMYELITIS; RANDOMIZED CONTROLLED TRIAL; SEROCONVERSION; SEROTYPE; SINGLE DRUG DOSE; VACCINATION; VIRUS SHEDDING; BLOOD; IMMUNOLOGY; INFANT; INTESTINE; INTRAMUSCULAR DRUG ADMINISTRATION; POLIOMYELITIS VIRUS; PRESCHOOL CHILD; PROCEDURES; SECONDARY IMMUNIZATION; TREATMENT OUTCOME;

ANTIBODIES, VIRAL; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; INFANT; INJECTIONS, INTRAMUSCULAR; INTESTINES; MALE; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINE, INACTIVATED; POLIOVIRUS VACCINE, ORAL; TREATMENT OUTCOME; VACCINATION; VIRUS SHEDDING;

EID: 84908336634     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)60934-X     Document Type: Article

References (29)

1. Global Polio Eradication Initiative Polio eradication and endgame strategic plan 2013-2018 http://bit.ly/1649OwE (accessed April 23, 2014).
2. NC Grassly, C Fraser, J Wenger et al. New strategies for the elimination of polio from India Science 314 2006 1150 1153
3. NC Grassly, H Jafari, S Bahl et al. Waning intestinal immunity following vaccination with oral poliovirus vaccines in India J Infect Dis 205 2012 1554 1561
4. NC Grassly, H Jafari, S Bahl et al. Asymptomatic wild poliovirus infection in India among children previously immunized with oral poliovirus vaccine J Infect Dis 201 2010 1535 1543
5. Mach O, Verma H, Khandait D, et al. Prevalence of asymptomatic poliovirus infection in older children and adults in northern India: analysis of contact and community enhanced surveillance, 2009. J Infect Dis (in press).
6. M Kojouharova, PLF Zuber, S Gyurova et al. Importation and circulation of poliovirus in Bulgaria in 2001 Bull World Health Organ 81 2003 476 481
7. S Kidd, JL Goodson, J Aramburu et al. Poliomyelitis outbreaks in Angola genetically linked to India: Risk factors and implications for prevention of outbreaks due to wild poliovirus importations Vaccine 29 2011 3760 3766
8. E Vidor, C Meschievitz, S Plotkin Fifteen years of experience with Vero-produced enhanced potency inactivated poliovirus vaccine Pediatr Infect Dis J 16 1997 312 322
9. TM Herremans, JH Reimerink, AM Buisman, TG Kimman, MP Koopmans Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus J Immunol 162 1999 5011 5018
10. T Herremans, TG Kimman, MAE Conyn-van Spaendonck et al. Immunoglobulin A as a serological marker for the (silent) circulation of poliovirus in an inactivated poliovirus-vaccinated population Clin Infect Dis 34 2002 1067 1075
11. TR Hird, NC Grassly Systematic review of mucosal immunity induced by oral and inactivated poliovirus vaccines against virus shedding following oral poliovirus challenge PLoS Pathog 8 2012 e1002599
12. TD Mangal, RB Aylward, NC Grassly The impact of routine immunisation with inactivated poliovirus vaccine on wild-type or vaccine-derived poliovirus outbreaks in a post-eradication setting Am J Epidemiol 178 2013 1579 1587
13. Y Manor, LM Shulman, E Kaliner et al. Intensified environmental surveillance supporting the response to wild poliovirus type 1 silent circulation in Israel, 2013 Euro Surveill 19 2014 20708
14. WHO Collaborative Study Group on Oral and Inactivated Poliovirus Vaccines Combined immunization of infants with oral and inactivated poliovirus vaccines: results of a randomized trial in The Gambia, Oman, and Thailand J Infect Dis 175 1997 S215 S227
15. JF Modlin, NA Halsey, ML Thoms, CK Meschievitz, PA Patriarca Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine - live attenuated oral poliovirus vaccine immunization schedules J Infect Dis 175 1997 S228 SS34
16. IP du Chatelet, AT Merchant, S Fisher-Hoch et al. Serological response and poliovirus excretion following different combined oral and inactivated poliovirus vaccines immunization schedules Vaccine 21 2003 1710 1718
17. C Krieg, R Maier, A Meyerhans Gut-homing (a4b7+) Th1 memory responses after inactivated poliovirus immunization in poliovirus orally pre-immunized donors J Gen Virol 85 2004 1571 1579
18. H Faden, L Duffy Effect of concurrent viral infection on systemic and local antibody responses to live attenuated and enhanced-potency inactivated poliovirus vaccines Am J Dis Child 146 1992 1320 1323
19. BJ Moriniere, FP van Loon, PH Rhodes et al. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine Lancet 341 1993 1545 1550
20. CF Estivariz, H Jafari, RW Sutter et al. Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial Lancet Infect Dis 12 2012 128 135
21. RW Sutter, AJM Suleiman, P Malankar et al. Trial of a supplemental dose of four poliovirus vaccines N Engl J Med 343 2000 767 773
22. WHO Manual of laboratory methods for testing of vaccines used in the WHO Expanded Programme on Immunization 1997 World Health Organization Geneva http://apps.who.int/iris/handle/10665/63576 (accessed June 17, 2014).
23. DR Kilpatrick, C-F Yang, K Ching et al. Rapid group-, serotype-, and vaccine strain-specific identification of poliovirus isolates by real-time reverse transcription-PCR using degenerate primers and probes containing deoxyinosine residues J Clin Microbiol 47 2009 1939 1941
24. WHO Polio laboratory manual 2004 World Health Organization Geneva http://whqlibdoc.who.int/hq/2004/WHO-IVB-04.10.pdf (accessed April 23, 2014).
25. CJ Clopper, ES Pearson The use of confidence or fiducial limits illustrated in the case of the binomial Biometrika 26 1934 404 413
26. RG Newcombe Confidence intervals for proportions and related measures of effect size 2012 CRC Press Boca Raton
27. PA Patriarca, PF Wright, TJ John Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: Review Rev Infect Dis 13 1991 926 939
28. K Katrak, BP Mahon, PD Minor, KHG Mills Cellular and humoral immune-responses to poliovirus in mice - a role for helper t-cells in heterotypic immunity to poliovirus J Gen Virol 72 1991 1093 1098
29. Z Chen, ER Fischer, D Kouiavskaia et al. Cross-neutralizing human anti-poliovirus antibodies bind the recognition site for cellular receptor Proc Natl Acad Sci USA 110 2013 20242 20247